Introduction: Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial. Methods: Sixty patients were randomized into 2 age-matched groups: Group A – treatment and Group B – placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient’s and partner’s subjective satisfaction. Results: A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p = 0.049 and p < 0.001, respectively), the EHS after week 12 (p < 0.001), an increase in the EHS after 4 and 12 weeks (p = 0.030 and p < 0.001, respectively), after 12 weeks in GAQ (p < 0.001), SEP 2 (p = 0.05), SEP 3 (p < 0.001), and patient’s satisfaction (p < 0.001) and partner’s satisfaction (p < 0.001). Conclusions: The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.

1.
Montorsi
F
,
Adaikan
G
,
Becher
E
,
Giuliano
F
,
Khoury
S
,
Lue
TF
, et al.
Summary of the recommendations on sexual dysfunctions in men
.
J Sex Med
.
2010
Nov
;
7
(
11
):
3572
88
.
[PubMed]
1743-6095
2.
Shamloul
R
,
Ghanem
H
.
Erectile dysfunction
.
Lancet
.
2013
Jan
;
381
(
9861
):
153
65
.
[PubMed]
0140-6736
3.
Ludwig
W
,
Phillips
M
.
Organic causes of erectile dysfunction in men under 40
.
Urol Int
.
2014
;
92
(
1
):
1
6
.
[PubMed]
0042-1138
4.
Feldman
HA
,
Goldstein
I
,
Hatzichristou
DG
,
Krane
RJ
,
McKinlay
JB
.
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study
.
J Urol
.
1994
Jan
;
151
(
1
):
54
61
.
[PubMed]
0022-5347
5.
Hatzimouratidis
K
,
Giuliano
F
,
Moncada
I
,
Muneer
A
,
Salonia
A
,
Verze
P
, et al.
EAU Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.
https://uroweb.org/guideline/male-sexual-dysfunction/
6.
García-Perdomo
HA
,
Echeverría-García
F
,
Tobías
A
.
Effectiveness of phosphodiesterase 5 inhibitors in the treatmetn of erectile dysfunction in patients with spinal cord trauma: systematic review and meta-amalysisi
.
Urol Int
.
2017
;
98
(
2
):
198
204
.
[PubMed]
0042-1138
7.
Carvalheira
AA
,
Pereira
NM
,
Maroco
J
,
Forjaz
V
.
Dropout in the treatment of erectile dysfunction with PDE5: a study on predictors and a qualitative analysis of reasons for discontinuation
.
J Sex Med
.
2012
Sep
;
9
(
9
):
2361
9
.
[PubMed]
1743-6095
8.
Sahin
MO
,
Sen
V
,
Eser
E
,
Koc
E
,
Gumus
U
,
Karakuzu
C
, et al.
The effect of hyperbaric oxygen therapy on erectile dysfunctions: A prospective clinical study
.
Urol Int
.
2018
;
101
(
2
):
206
11
.
[PubMed]
0042-1138
9.
Al Demour
S
,
Jafar
H
,
Adwan
S
.
AISharif A, Alhawarti H, Alrabadi A, Zayed A, Jaradat A, Awidi A. Safety and potential therapeutic effect of two intracavernous autologous bone marrow derivec, mesenchymal stem cells injectioons id diabetic patietns with erectile dyfunkction: an open label phase I clinical trial
.
Urol Int
.
2018
;
101
(
3
):
358
65
.
[PubMed]
0042-1138
10.
Fojecki
GL
,
Tissen
S
,
Osther
P
.
Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain
.
World J Urol
.
2016
;
14
(
1
):
106
.
[PubMed]
0724-4983
11.
Nishida
T
,
Shimokawa
H
,
Oi
K
,
Tatewaki
H
,
Uwatoku
T
,
Abe
K
, et al.
Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo
.
Circulation
.
2004
Nov
;
110
(
19
):
3055
61
.
[PubMed]
0009-7322
12.
Vardi
Y
,
Appel
B
,
Kilchevsky
A
,
Gruenwald
I
.
Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study
.
J Urol
.
2012
May
;
187
(
5
):
1769
75
.
[PubMed]
0022-5347
13.
Vardi
Y
,
Appel
B
,
Jacob
G
,
Massarwi
O
,
Gruenwald
I
.
Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction
.
Eur Urol
.
2010
Aug
;
58
(
2
):
243
8
.
[PubMed]
0302-2838
14.
Gruenwald
I
,
Kitrey
ND
,
Appel
B
,
Vardi
Y
.
Low-intensity extracorporeal shock wave therapy in vascular disease and erectile dysfunction: theory and outcomes
.
Sex Med Rev
.
2013
Jul
;
1
(
2
):
83
90
.
[PubMed]
2050-0513
15.
Rosen
RC
,
Riley
A
,
Wagner
G
,
Osterloh
IH
,
Kirkpatrick
J
,
Mishra
A
.
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
.
Urology
.
1997
Jun
;
49
(
6
):
822
30
.
[PubMed]
0090-4295
16.
Goldstein
I
,
Mulhall
JP
,
Bushmakin
AG
,
Cappelleri
JC
,
Hvidsten
K
,
Symonds
T
.
The erection hardness score and its relationship to successful sexual intercourse
.
J Sex Med
.
2008
Oct
;
5
(
10
):
2374
80
.
[PubMed]
1743-6095
17.
Araujo
AB
,
Allen
KR
,
Ni
X
,
Rosen
RC
.
Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile
.
J Sex Med
.
2012
Jan
;
9
(
1
):
169
79
.
[PubMed]
1743-6095
18.
Sokolakis
I
,
Hatzichristodoulou
G
.
Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials
.
Int J Impot Res
.
2019
May
;
31
(
3
):
177
94
.
[PubMed]
0955-9930
19.
Yamaçake
KG
,
Carneiro
F
,
Cury
J
,
Lourenço
R
,
Françolin
PC
,
Piovesan
AC
, et al.
Low-intensity shockwave therapy for erectile dysfunction in kidney transplant recipients. A prospective, randomized, double blinded, sham-controlled study with evaluation by penile Doppler ultrasonography
.
Int J Impot Res
.
2019
May
;
31
(
3
):
195
203
.
[PubMed]
0955-9930
20.
Clavijo
RI
,
Kohn
TP
,
Kohn
JR
,
Ramasamy
R
.
Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: A systematic review and meta-analysis
.
J Sex Med
.
2017
Jan
;
14
(
1
):
27
35
.
[PubMed]
1743-6095
21.
Man
L
,
Li
G
.
Low-intensity extracorporeal shock wave therapy for erectile dysfunction: a systematic review and meta-analysis
.
Urology
.
2018
Sep
;
119
:
97
103
.
[PubMed]
0090-4295
22.
Olsen
AB
,
Persiani
M
,
Boie
S
,
Hanna
M
,
Lund
L
.
Can low-intensity extracorporeal shockwave therapy improve erectile dysfunction? A prospective, randomized, double-blind, placebo-controlled study
.
Scand J Urol
.
2015
;
49
(
4
):
329
33
.
[PubMed]
2168-1805
23.
Feldman
R
,
Denes
B
,
Appel
B
,
Vasan
SS
,
Shultz
T
,
Burnett
A
.
The safety and efficacy of Li-ESWT in 604 patients for erectile dysfunction: summary of current and evolving evidence
.
J Urol
.
2015
;
193
(
4
suppl
):
e905
. 0022-5347
24.
Bechara
A
,
Casabé
A
,
De Bonis
W
,
Ciciclia
PG
.
Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors
.
Sex Med
.
2016
Dec
;
4
(
4
):
e225
32
.
[PubMed]
2050-1161
25.
Zewin
TS
,
El-Assmy
A
,
Harraz
AM
,
Bazeed
M
,
Shokeir
AA
,
Sheir
K
, et al.
Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial
.
Int Urol Nephrol
.
2018
Nov
;
50
(
11
):
2007
14
.
[PubMed]
0301-1623
26.
Tsai
CC
,
Wang
CJ
,
Lee
YC
,
Kuo
YT
,
Lin
HH
,
Li
CC
, et al.
Low- intensity extracorporeal shockwave therapy can improve erectile function in patients who failed to respond to phpsphodiesterase type 5 inhibitors
.
Am J Men Health
.
2017
Nov
;
11
(
6
):
1781
90
.
[PubMed]
1557-9883
27.
Kitrey
ND
,
Gruenwald
I
,
Appel
B
,
Shechter
A
,
Massarwa
O
,
Vardi
Y
.
Penile low intensity shock wave treatment is able to shift PDE5i nonresponders to responders: A double blind sham controlled study
.
J Urol
.
2016
May
;
195
(
5
):
1550
5
.
[PubMed]
0022-5347
28.
Fojecki
GL
,
Tiessen
S
,
Osther
PJ
.
Effect of Low-Energy linear shockwave therapy on erectile dysfunction – a double blinded, sham-controlled, randomized clinical trial
.
J Sex Med
.
2017
Jan
;
14
(
1
):
106
12
.
[PubMed]
1743-6095
29.
Lu
Z
,
Lin
G
,
Reed-Maldonado
A
,
Wang
C
,
Lee
YC
,
Lue
TF
.
Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis
.
Eur Urol
.
2017
Feb
;
71
(
2
):
223
33
.
[PubMed]
0302-2838
30.
Gotte
G
,
Amelio
E
,
Russo
S
,
Marlinghaus
E
,
Musci
G
,
Suzuki
H
.
Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment
.
FEBS Lett
.
2002
Jun
;
520
(
1-3
):
153
5
.
[PubMed]
0014-5793
31.
Hatzichristou
D
.
Low-Intensity Extracorporeal Shock Waves Therapy (LI-ESWT) for the treatment of erectile dysfunction: where do we stand?
Eur Urol
.
2017
Feb
;
71
(
2
):
234
6
.
[PubMed]
0302-2838
32.
Usta
MF
,
Gabrielson
AT
,
Bivalacqua
TJ
.
Low-intensity extracorporeal shockwave therapy in the treatment of erectile dysfunction following radical prostatectomy: a critical review
.
Int J Impot Res
.
2019
May
;
31
(
3
):
231
8
.
[PubMed]
0955-9930
33.
Frey
A
,
Sønksen
J
,
Fode
M
.
Low-intensity extracorporeal shockwave therapy in the treatment of postprostatectomy erectile dysfunction: a pilot study
.
Scand J Urol
.
2016
;
50
(
2
):
123
7
.
[PubMed]
2168-1805
34.
Fode
M
,
Hatzichristodoulou
G
,
Serefoglu
EC
,
Verze
P
,
Albersen
M
;
Young Academic Urologists Men’s Health Group
.
Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?
Nat Rev Urol
.
2017
Oct
;
14
(
10
):
593
606
.
[PubMed]
1759-4812
35.
Fode
M
,
Russo
GI
,
Verze
P
.
Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction
.
Int J Impot Res
.
2019
May
;
31
(
3
):
223
30
.
[PubMed]
0955-9930
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.